Search

Bausch Health Cos Inc

Gesloten

SectorGezondheidszorg

6.33 2.26

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

6.17

Max

6.38

Belangrijke statistieken

By Trading Economics

Inkomsten

1.7B

260M

Verkoop

363M

2.9B

K/W

Sectorgemiddelde

13.286

57.002

EPS

1.26

Winstmarge

9.116

Werknemers

20,300

EBITDA

1.7B

1B

Aanbevelingen

By TipRanks

Aanbevelingen

Neutraal

12 Maanden Prognose

+28.82% upside

Dividenden

By Acuity

Volgende Winsten

28 okt 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

702M

2.4B

Vorige openingsprijs

4.07

Vorige sluitingsprijs

6.33

Nieuwssentiment

By Acuity

20%

80%

32 / 340 Rangschikking in Healthcare

Bausch Health Cos Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

12 aug 2026, 23:56 UTC

News

Allegro Microsystems shares rose in after-market trading following Benchmark's initiation of coverage with a Buy rating. The stock closed at $42.52.

12 aug 2026, 23:56 UTC

Social Media
News

STAAR Surgical shares are lower in after-market hours following an EPS miss, despite reporting second-quarter net sales of $93.5 million, a 111% increase.

12 aug 2026, 23:51 UTC

News

Fossil Group Inc reported second-quarter sales of $209.7 million, exceeding expectations. Shares are trading sharply higher in after-market hours.

12 aug 2026, 23:51 UTC

Social Media
News

PTC Therapeutics acquires ST-920 gene therapy for $111 million, enhancing its rare disease portfolio. Shares are higher in after-market hours.

12 aug 2026, 23:51 UTC

Social Media
News

Harmonic Inc. reported strong Q2 results, with adjusted EPS of $0.24 and raised full-year guidance, leading shares higher in after-market hours.

12 aug 2026, 23:51 UTC

News
Social Media

Omeros Corp reported second-quarter revenues of $32.2 million, exceeding expectations. Shares rose in after-market trading following the strong financial results and Medicare approval.

12 aug 2026, 23:46 UTC

News

Cummins shares are higher in after-market trading following strong Q2 earnings of $9.46 billion, surpassing analyst expectations despite an adjusted EPS miss.

12 aug 2026, 23:46 UTC

News

Wendy's shares declined in after-market hours after earlier gains on news of a potential buyout bid from Nelson Peltz's Trian Fund Management.

12 aug 2026, 23:41 UTC

News

Granite Construction secures a $31 million contract for the Willow Rock Energy Storage Center, boosting its project portfolio. Shares are higher in after-market trading.

12 aug 2026, 23:41 UTC

News

Mistras Group raised its fiscal year revenue guidance to $740-$755 million, driving shares higher in after-market trading. Adjusted EBITDA is expected around $93.5 million.

12 aug 2026, 23:41 UTC

News
Social Media

Jack in the Box Inc. reports third-quarter earnings with EPS of $1.08, exceeding expectations. The stock is trading higher in after-market hours.

12 aug 2026, 23:41 UTC

Social Media
News

EnerSys reported strong first-quarter results, with adjusted EPS of $3.66 and revenue of $935.6 million. Shares are higher in after-market trading.

12 aug 2026, 23:41 UTC

News
Social Media

Coherent Corp shares fell in after-hours trading despite strong fourth-quarter results, including adjusted EPS of $1.74 and revenue of $2.05 billion.

12 aug 2026, 23:41 UTC

Social Media
News

Enovix Corp shares are lower in after-market hours following mixed second-quarter results and lower-than-expected third-quarter revenue guidance.

12 aug 2026, 23:36 UTC

Social Media
News

Cheniere Energy raised its 2026 earnings and production guidance despite a quarterly loss. Shares are higher in after-market trading amid rising natural gas prices.

12 aug 2026, 23:36 UTC

News

Alexandria Real Estate Equities has priced a $1 billion offering of 7.250% junior subordinated notes, with shares modestly higher in after-market trading.

12 aug 2026, 23:36 UTC

News

Nasdaq Inc. shares gained in after-market trading, reaching a monthly high as inflation data eased concerns over Federal Reserve rate hikes.

12 aug 2026, 23:26 UTC

News

Red Robin Gourmet Burgers shares rose in after-market trading following a Q2 earnings report that showed adjusted earnings and revenue exceeding analyst expectations.

12 aug 2026, 23:26 UTC

News

Trian Fund Management increased its stake in GE Healthcare Technologies to 3.1 million shares, contributing to a modest rise in after-market hours.

12 aug 2026, 23:26 UTC

News
Correlated Moves

Vishay Intertechnology announced a quarterly dividend of $0.10 per share, enhancing investor sentiment as shares trade higher in after-market hours.

12 aug 2026, 23:21 UTC

News

Duke Energy has restored power to over 171,000 customers in Greater Cincinnati. Shares are gaining in after-market hours amid this progress.

12 aug 2026, 23:21 UTC

News

Allogene Therapeutics reports narrower net loss of $42.7 million, revenue of $4.64 million. Shares higher after positive trial results and $500 million securities offering announcement.

12 aug 2026, 23:11 UTC

News

Goldman Sachs will acquire NEOS Investments for up to $2.25 billion, enhancing its asset management division with new income ETFs. Shares are higher in after-market trading.

12 aug 2026, 23:06 UTC

News

Spero Therapeutics reports FDA approval of Utebzi and secures $105 million financing. Shares are trading higher in after-market hours.

12 aug 2026, 23:06 UTC

News
Social Media

Meta Platforms faces a federal trial over youth safety violations. In after-market trading, shares are slightly higher despite ongoing legal challenges.

12 aug 2026, 23:06 UTC

News

Phillips 66 shares rose in after-market trading following a strong second-quarter performance and a $10 billion increase in buyback authorization.

12 aug 2026, 23:06 UTC

News

FormFactor Inc will participate in key investor conferences, boosting market interest. Shares are higher in after-market trading following the announcement.

12 aug 2026, 23:06 UTC

Social Media
News

NextEra Energy has secured a $3.3 billion investment for natural gas projects in Texas and Pennsylvania, though shares are trading lower in after-market hours.

12 aug 2026, 23:02 UTC

Social Media
News

Pfizer shares rose after Chairman Albert Bourla bought 38,000 shares at $26.34, totaling about $1 million, signaling confidence in the company's prospects.

12 aug 2026, 23:01 UTC

News

Kimball Electronics shares are lower in after-market trading following a quarterly adjusted EPS loss of $0.01, missing expectations of $0.39.

Peer Vergelijking

Prijswijziging

Bausch Health Cos Inc Prognose

Koersdoel

By TipRanks

28.82% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 8 USD  28.82%

Hoogste 9 USD

Laagste 7 USD

Gebaseerd op 2 Wall Street-analisten die 12-maands prijsdoelen bieden voor Bausch Health Cos Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Neutraal

2 ratings

0

Buy

2

Hold

0

Sell

Sentiment

By Acuity

32 / 340 Rangschikking in Gezondheidszorg

Nieuwssentiment

Zeer Sterk Bearish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Boven gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Bausch Health Cos Inc

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products in the United States. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products internationally. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; generic products; ortho dermatologic; and dentistry products in the United States. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.
help-icon Live chat